Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Convoluted Herbal Requirements Foretell FSMA Complexities

This article was originally published in The Tan Sheet

Executive Summary

Ingredient importers supplying herbal materials for food and dietary supplement manufacturers will have to consider their downstream customers’ intended uses to comply with FDA regulations under the Food Safety Modernization Act, which are likely to vex many companies.

You may also be interested in...



Ingredient Specs Vital Under Both Supplement GMPs And FSMA Regs

Establishing and testing for ingredient specifications are a crucial part of dietary supplement good manufacturing practices, and likely will be under the food safety preventive controls rule once that regulation is finalized, FDA’s Daniel Fabricant says.

Ingredient Specs Vital Under Both Supplement GMPs And FSMA Regs

Establishing and testing for ingredient specifications are a crucial part of dietary supplement good manufacturing practices, and likely will be under the food safety preventive controls rule once that regulation is finalized, FDA’s Daniel Fabricant says.

FSMA Supplier Verification Rule Affects Finished Supplement Importers

Proposed FSMA rules would subject imported food products, including supplements, to the same safety standards as domestically produced food. The proposals are reminders that although supplement manufacturing is exempt from FSMA provisions redundant to GMP requirements, the act adds regulatory burdens for some firms.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106608

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel